世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

吸入器とネブライザーの世界市場の洞察、2028年までの予測


Global Inhalers and Nebulizers Market Insights, Forecast to 2028

市場の分析と洞察。吸入器とネブライザーの世界市場 COVID-19の大流行により、吸入器とネブライザーの世界市場規模は2022年に14647百万米ドルと推定され、2028年には18403百万米ドルに再調整され、予測期間2022-... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年10月24日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。吸入器とネブライザーの世界市場
COVID-19の大流行により、吸入器とネブライザーの世界市場規模は2022年に14647百万米ドルと推定され、2028年には18403百万米ドルに再調整され、予測期間2022-2028年にはCAGR3.88%になると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に吸入器とネブライザーの世界市場の92.09%を占めた吸入器は、2028年までに1億6742万米ドルの価値を持ち、2022年から2028年までCAGR3.69%で成長すると予測されています。喘息分野は、この予測期間を通じてCAGR3.75%に変化しています。
吸入器とネブライザーの世界的な主要メーカーは、GSK、アストラゼネカ、Chiesi、Teva、ベーリンガーインゲルハイム、ノバルティス、オルガノン、オムロン、フィリップスなどです。2021年、世界の上位5社は売上高で約76.61%のシェアを占めています。

世界の吸入器・ネブライザーの範囲とセグメント
吸入器とネブライザー市場は、タイプ別、用途別に分類されています。吸入器とネブライザーの世界市場におけるプレイヤー、利害関係者、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

企業別
GSK
アストラゼネカ
Chiesi
テバ
ベーリンガーインゲルハイム
ノバルティス
オルガノン
オムロン
フィリップス
PARI社
ユウェル
ドライブ・デビルビス・ヘルスケア
Leyi
フォリー
ベアラ

タイプ別セグメント
吸入器
ネブライザー

用途別セグメント
気管支喘息
慢性閉塞性肺疾患
その他

地域別セグメント
北米
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア
欧州
ドイツ
フランス
英国
イタリア
ロシア

南米
ブラジル

中東・アフリカ
中東
アフリカ



ページTOPに戻る


目次

1 Study Coverage 1
1.1 Inhalers And Nebulizers Product Introduction 1
1.2 Market By Type 2
1.2.1 Global Inhalers And Nebulizers Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 2
1.2.2 Inhalers 4
1.2.3 Nebulizer 5
1.3 Market By Application 6
1.3.1 Global Inhalers And Nebulizers Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 6
1.3.2 Asthma 8
1.3.3 Copd 9
1.4 Study Objectives 10
1.5 Years Considered 11
2 Executive Summary 12
2.1 Global Inhalers And Nebulizers Sales Estimates And Forecasts 2017-2028 12
2.2 Global Inhalers And Nebulizers Revenue Estimates And Forecasts 2017-2028 13
2.3 Global Inhalers And Nebulizers Revenue By Region: 2017 Vs 2021 Vs 2028 14
2.4 Global Inhalers And Nebulizers Sales By Region 16
2.4.1 Global Inhalers And Nebulizers Sales By Region (2017-2022) 16
2.4.2 Global Sales Inhalers And Nebulizers By Region (2023-2028) 17
2.5 Global Inhalers And Nebulizers Revenue By Region 18
2.5.1 Global Inhalers And Nebulizers Revenue By Region (2017-2022) 18
2.5.2 Global Inhalers And Nebulizers Revenue By Region (2023-2028) 19
2.6 North America 20
2.7 Europe 21
2.8 Asia-Pacific 22
2.9 South America 23
2.10 Middle East & Africa 24
3 Competition By Manufacturers 26
3.1 Global Inhalers And Nebulizers Sales By Manufacturers 26
3.1.1 Global Inhalers And Nebulizers Sales By Manufacturers (2017-2022) 26
3.1.2 Global Inhalers And Nebulizers Sales Market Share By Manufacturers (2017-2022) 27
3.1.3 Global Top Largest Manufacturers Of Inhalers And Nebulizers In 2021 28
3.2 Global Inhalers And Nebulizers Revenue By Manufacturers 29
3.2.1 Global Inhalers And Nebulizers Revenue By Manufacturers (2017-2022) 29
3.2.2 Global Inhalers And Nebulizers Revenue Market Share By Manufacturers (2017-2022) 30
3.2.3 Global Top Companies By Inhalers And Nebulizers Revenue In 2021 30
3.3 Global Inhalers And Nebulizers Sales Price By Manufacturers (2017-2022) 31
3.4 Analysis Of Competitive Landscape 32
3.4.1 Manufacturers Market Concentration Ratio (Cr5 And Hhi) 32
3.4.2 Global Inhalers And Nebulizers By Company Type (Tier 1, Tier 2, And Tier 3) 33
3.4.3 Global Inhalers And Nebulizers Sales Areas And Headquarters 34
3.5 Mergers & Acquisitions, Expansion Plans 36
4 Market Size By Type 39
4.1 Global Inhalers And Nebulizers Sales By Type 39
4.1.1 Global Inhalers And Nebulizers Historical Sales By Type (2017-2022) 39
4.1.2 Global Inhalers And Nebulizers Forecasted Sales By Type (2023-2028) 39
4.1.3 Global Inhalers And Nebulizers Sales Market Share By Type (2017-2028) 39
4.2 Global Inhalers And Nebulizers Revenue By Type 41
4.2.1 Global Inhalers And Nebulizers Historical Revenue By Type (2017-2022) 41
4.2.2 Global Inhalers And Nebulizers Forecasted Revenue By Type (2023-2028) 41
4.2.3 Global Inhalers And Nebulizers Revenue Market Share By Type (2017-2028) 41
4.3 Global Inhalers And Nebulizers Price By Type 42
4.3.1 Global Inhalers And Nebulizers Price By Type (2017-2022) 42
4.3.2 Global Inhalers And Nebulizers Price Forecast By Type (2023-2028) 43
5 Market Size By Application 44
5.1 Global Inhalers And Nebulizers Sales By Application 44
5.1.1 Global Inhalers And Nebulizers Historical Sales By Application (2017-2022) 44
5.1.2 Global Inhalers And Nebulizers Forecasted Sales By Application (2023-2028) 44
5.1.3 Global Inhalers And Nebulizers Sales Market Share By Application (2017-2028) 45
5.2 Global Inhalers And Nebulizers Revenue By Application 46
5.2.1 Global Inhalers And Nebulizers Historical Revenue By Application (2017-2022) 46
5.2.2 Global Inhalers And Nebulizers Forecasted Revenue By Application (2023-2028) 46
5.2.3 Global Inhalers And Nebulizers Revenue Market Share By Application (2017-2028) 47
5.3 Global Inhalers And Nebulizers Price By Application 48
5.3.1 Global Inhalers And Nebulizers Price By Application (2017-2022) 48
5.3.2 Global Inhalers And Nebulizers Price Forecast By Application (2023-2028) 48
6 North America 49
6.1 North America Inhalers And Nebulizers Market Size By Type 49
6.1.1 North America Inhalers And Nebulizers Sales By Type (2017-2028) 49
6.1.2 North America Inhalers And Nebulizers Revenue By Type (2017-2028) 50
6.2 North America Inhalers And Nebulizers Market Size By Application 51
6.3 North America Inhalers And Nebulizers Sales By Country 52
6.3.1 North America Inhalers And Nebulizers Sales By Country (2017-2028) 52
6.3.2 North America Inhalers And Nebulizers Revenue By Country (2017-2028) 54
6.3.3 United States 55
6.3.4 Canada 56
6.3.5 Mexico 56
7 Europe 57
7.1 Europe Inhalers And Nebulizers Market Size By Type 57
7.1.1 Europe Inhalers And Nebulizers Sales By Type (2017-2028) 57
7.1.2 Europe Inhalers And Nebulizers Revenue By Type (2017-2028) 58
7.2 Europe Inhalers And Nebulizers Market Size By Application 59
7.3 Europe Inhalers And Nebulizers Market Size By Country 60
7.3.1 Europe Inhalers And Nebulizers Sales By Country (2017-2028) 60
7.3.2 Europe Inhalers And Nebulizers Revenue By Country (2017-2028) 62
7.3.3 Germany 63
7.3.4 France 64
7.3.5 U.K. 64
7.3.6 Italy 65
7.3.7 Russia 65
8 Asia Pacific 66
8.1 Asia Pacific Inhalers And Nebulizers Market Size By Type 66
8.1.1 Asia Pacific Inhalers And Nebulizers Sales By Type (2017-2028) 66
8.1.2 Asia Pacific Inhalers And Nebulizers Revenue By Type (2017-2028) 67
8.2 Asia Pacific Inhalers And Nebulizers Market Size By Application 68
8.3 Asia Pacific Inhalers And Nebulizers Market Size By Region 69
8.3.1 Asia Pacific Inhalers And Nebulizers Sales By Region (2017-2028) 69
8.3.2 Asia Pacific Inhalers And Nebulizers Revenue By Region (2017-2028) 71
8.3.3 China 72
8.3.4 Japan 73
8.3.5 South Korea 73
8.3.6 India 74
8.3.7 Australia 74
8.3.8 Southeast Asia 75
9 South America 76
9.1 South America Inhalers And Nebulizers Market Size By Type 76
9.1.1 South America Inhalers And Nebulizers Sales By Type (2017-2028) 76
9.1.2 South America Inhalers And Nebulizers Revenue By Type (2017-2028) 77
9.2 South America Inhalers And Nebulizers Market Size By Application 78
9.3 South America Inhalers And Nebulizers Market Size By Country 79
9.3.1 South America Inhalers And Nebulizers Sales By Country (2017-2028) 79
9.3.2 South America Inhalers And Nebulizers Revenue By Country (2017-2028) 81
9.3.3 Brazil 82
10 Middle East And Africa 83
10.1 Middle East And Africa Inhalers And Nebulizers Market Size By Type 83
10.1.1 Middle East And Africa Inhalers And Nebulizers Sales By Type (2017-2028) 83
10.1.2 Middle East And Africa Inhalers And Nebulizers Revenue By Type (2017-2028) 84
10.2 Middle East And Africa Inhalers And Nebulizers Market Size By Application 85
10.3 Middle East And Africa Inhalers And Nebulizers Market Size By Country 87
10.3.1 Middle East And Africa Inhalers And Nebulizers Sales By Country (2017-2028) 87
10.3.2 Middle East And Africa Inhalers And Nebulizers Revenue By Country (2017-2028) 87
10.3.3 Middle East 89
10.3.4 Africa 89
11 Corporate Profile 90
11.1 Gsk 90
11.1.1 Gsk Corporation Information 90
11.1.2 Gsk Overview 90
11.1.3 Gsk Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 91
11.1.4 Gsk Inhalers And Nebulizers Product Introduction 91
11.1.5 Gsk Recent Developments 93
11.2 Astrazeneca 94
11.2.1 Astrazeneca Corporation Information 94
11.2.2 Astrazeneca Overview 94
11.2.3 Astrazeneca Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 95
11.2.4 Astrazeneca Inhalers And Nebulizers Product Introduction 95
11.2.5 Astrazeneca Recent Developments 96
11.3 Chiesi 97
11.3.1 Chiesi Corporation Information 97
11.3.2 Chiesi Overview 97
11.3.3 Chiesi Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 98
11.3.4 Chiesi Inhalers And Nebulizers Product Introduction 98
11.4 Boehringer Ingelheim 100
11.4.1 Boehringer Ingelheim Corporation Information 100
11.4.2 Boehringer Ingelheim Overview 101
11.4.3 Boehringer Ingelheim Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 101
11.4.4 Boehringer Ingelheim Inhalers And Nebulizers Product Introduction 102
11.4.5 Boehringer Ingelheim Recent Developments 102
11.5 Novartis 103
11.5.1 Novartis Corporation Information 103
11.5.2 Novartis Overview 103
11.5.3 Novartis Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 104
11.5.4 Novartis Inhalers And Nebulizers Product Introduction 105
11.5.5 Novartis Recent Developments 106
11.6 Teva 107
11.6.1 Teva Corporation Information 107
11.6.2 Teva Overview 107
11.6.3 Teva Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 108
11.6.4 Teva Inhalers And Nebulizers Product Introduction 108
11.7 Organon 109
11.7.1 Organon Corporation Information 109
11.7.2 Organon Overview 110
11.7.3 Organon Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 111
11.7.4 Organon Inhalers And Nebulizers Product Introduction 111
11.7.5 Organon Recent Developments 112
11.8 Pari Gmbh 113
11.8.1 Pari Gmbh Corporation Information 113
11.8.2 Pari Gmbh Overview 114
11.8.3 Pari Gmbh Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 114
11.8.4 Pari Gmbh Inhalers And Nebulizers Product Introduction 115
11.9 Omron 116
11.9.1 Omron Corporation Information 116
11.9.2 Omron Overview 116
11.9.3 Omron Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 117
11.9.4 Omron Inhalers And Nebulizers Product Introduction 117
11.10 Philips 118
11.10.1 Philips Corporation Information 118
11.10.2 Philips Overview 119
11.10.3 Philips Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 119
11.10.4 Philips Inhalers And Nebulizers Product Introduction 120
11.11 Drive Devilbiss Healthcare 121
11.11.1 Drive Devilbiss Healthcare Corporation Information 121
11.11.2 Drive Devilbiss Healthcare Overview 121
11.11.3 Drive Devilbiss Healthcare Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 122
11.11.4 Drive Devilbiss Healthcare Inhalers And Nebulizers Product Introduction 122
11.12 Yuwell 124
11.12.1 Yuwell Corporation Information 124
11.12.2 Yuwell Overview 124
11.12.3 Yuwell Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 125
11.12.4 Yuwell Inhalers And Nebulizers Product Introduction 125
11.13 Leyi 126
11.13.1 Leyi Corporation Information 126
11.13.2 Leyi Overview 127
11.13.3 Leyi Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 128
11.13.4 Leyi Inhalers And Nebulizers Product Introduction 128
11.14 Folee 129
11.14.1 Folee Corporation Information 129
11.14.2 Folee Overview 130
11.14.3 Folee Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 130
11.14.4 Folee Inhalers And Nebulizers Product Introduction 130
11.15 Beurer 131
11.15.1 Beurer Corporation Information 131
11.15.2 Beurer Overview 132
11.15.3 Beurer Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 132
11.15.4 Beurer Inhalers And Nebulizers Product Introduction 133
12 Industry Chain And Sales Channels Analysis 134
12.1 Inhalers And Nebulizers Industry Chain Analysis 134
12.2 Inhalers And Nebulizers Key Raw Materials 135
12.2.1 Key Raw Materials 135
12.2.2 Raw Materials Key Suppliers 135
12.3 Inhalers And Nebulizers Production Mode & Process 136
12.4 Inhalers And Nebulizers Sales And Marketing 137
12.4.1 Inhalers And Nebulizers Sales Channel 137
12.4.2 Inhalers And Nebulizers Distributors 139
12.5 Inhalers And Nebulizers Customers 141
13 Inhalers And Nebulizers Market Dynamics 144
13.1.1 Inhalers And Nebulizers Industry Trends 144
13.1.2 Inhalers And Nebulizers Market Drivers 145
13.1.3 Inhalers And Nebulizers Market Challenges 146
13.1.4 Inhalers And Nebulizers Market Restraints 146
14 Key Findings In The Global Inhalers And Nebulizers Study 147
15 Appendix 149
15.1 Research Methodology 149
15.1.1 Methodology/Research Approach 149
15.1.2 Data Source 153
15.2 Author Details 156
15.3 Disclaimer 157

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Inhalers and Nebulizers Market
Due to the COVID-19 pandemic, the global Inhalers and Nebulizers market size is estimated to be worth US$ 14647 million in 2022 and is forecast to a readjusted size of US$ 18403 million by 2028 with a CAGR of 3.88% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inhalers accounting for 92.09% of the Inhalers and Nebulizers global market in 2021, is projected to value US$ 16742 million by 2028, growing at a revised 3.69% CAGR from 2022 to 2028. While Asthma segment is altered to an 3.75% CAGR throughout this forecast period.
The global key manufacturers of Inhalers and Nebulizers include GSK, AstraZeneca, Chiesi, Teva, Boehringer Ingelheim, Novartis, Organon, Omron, Philips, etc. In 2021, the global top five players hold a share approximately 76.61% in terms of revenue.

Global Inhalers and Nebulizers Scope and Segment
Inhalers and Nebulizers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhalers and Nebulizers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
GSK
AstraZeneca
Chiesi
Teva
Boehringer Ingelheim
Novartis
Organon
Omron
Philips
PARI GmbH
Yuwell
Drive DeVilbiss Healthcare
Leyi
Folee
Beurer

Segment by Type
Inhalers
Nebulizer

Segment by Application
Asthma
COPD
Others

Segment by Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 Study Coverage 1
1.1 Inhalers And Nebulizers Product Introduction 1
1.2 Market By Type 2
1.2.1 Global Inhalers And Nebulizers Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 2
1.2.2 Inhalers 4
1.2.3 Nebulizer 5
1.3 Market By Application 6
1.3.1 Global Inhalers And Nebulizers Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 6
1.3.2 Asthma 8
1.3.3 Copd 9
1.4 Study Objectives 10
1.5 Years Considered 11
2 Executive Summary 12
2.1 Global Inhalers And Nebulizers Sales Estimates And Forecasts 2017-2028 12
2.2 Global Inhalers And Nebulizers Revenue Estimates And Forecasts 2017-2028 13
2.3 Global Inhalers And Nebulizers Revenue By Region: 2017 Vs 2021 Vs 2028 14
2.4 Global Inhalers And Nebulizers Sales By Region 16
2.4.1 Global Inhalers And Nebulizers Sales By Region (2017-2022) 16
2.4.2 Global Sales Inhalers And Nebulizers By Region (2023-2028) 17
2.5 Global Inhalers And Nebulizers Revenue By Region 18
2.5.1 Global Inhalers And Nebulizers Revenue By Region (2017-2022) 18
2.5.2 Global Inhalers And Nebulizers Revenue By Region (2023-2028) 19
2.6 North America 20
2.7 Europe 21
2.8 Asia-Pacific 22
2.9 South America 23
2.10 Middle East & Africa 24
3 Competition By Manufacturers 26
3.1 Global Inhalers And Nebulizers Sales By Manufacturers 26
3.1.1 Global Inhalers And Nebulizers Sales By Manufacturers (2017-2022) 26
3.1.2 Global Inhalers And Nebulizers Sales Market Share By Manufacturers (2017-2022) 27
3.1.3 Global Top Largest Manufacturers Of Inhalers And Nebulizers In 2021 28
3.2 Global Inhalers And Nebulizers Revenue By Manufacturers 29
3.2.1 Global Inhalers And Nebulizers Revenue By Manufacturers (2017-2022) 29
3.2.2 Global Inhalers And Nebulizers Revenue Market Share By Manufacturers (2017-2022) 30
3.2.3 Global Top Companies By Inhalers And Nebulizers Revenue In 2021 30
3.3 Global Inhalers And Nebulizers Sales Price By Manufacturers (2017-2022) 31
3.4 Analysis Of Competitive Landscape 32
3.4.1 Manufacturers Market Concentration Ratio (Cr5 And Hhi) 32
3.4.2 Global Inhalers And Nebulizers By Company Type (Tier 1, Tier 2, And Tier 3) 33
3.4.3 Global Inhalers And Nebulizers Sales Areas And Headquarters 34
3.5 Mergers & Acquisitions, Expansion Plans 36
4 Market Size By Type 39
4.1 Global Inhalers And Nebulizers Sales By Type 39
4.1.1 Global Inhalers And Nebulizers Historical Sales By Type (2017-2022) 39
4.1.2 Global Inhalers And Nebulizers Forecasted Sales By Type (2023-2028) 39
4.1.3 Global Inhalers And Nebulizers Sales Market Share By Type (2017-2028) 39
4.2 Global Inhalers And Nebulizers Revenue By Type 41
4.2.1 Global Inhalers And Nebulizers Historical Revenue By Type (2017-2022) 41
4.2.2 Global Inhalers And Nebulizers Forecasted Revenue By Type (2023-2028) 41
4.2.3 Global Inhalers And Nebulizers Revenue Market Share By Type (2017-2028) 41
4.3 Global Inhalers And Nebulizers Price By Type 42
4.3.1 Global Inhalers And Nebulizers Price By Type (2017-2022) 42
4.3.2 Global Inhalers And Nebulizers Price Forecast By Type (2023-2028) 43
5 Market Size By Application 44
5.1 Global Inhalers And Nebulizers Sales By Application 44
5.1.1 Global Inhalers And Nebulizers Historical Sales By Application (2017-2022) 44
5.1.2 Global Inhalers And Nebulizers Forecasted Sales By Application (2023-2028) 44
5.1.3 Global Inhalers And Nebulizers Sales Market Share By Application (2017-2028) 45
5.2 Global Inhalers And Nebulizers Revenue By Application 46
5.2.1 Global Inhalers And Nebulizers Historical Revenue By Application (2017-2022) 46
5.2.2 Global Inhalers And Nebulizers Forecasted Revenue By Application (2023-2028) 46
5.2.3 Global Inhalers And Nebulizers Revenue Market Share By Application (2017-2028) 47
5.3 Global Inhalers And Nebulizers Price By Application 48
5.3.1 Global Inhalers And Nebulizers Price By Application (2017-2022) 48
5.3.2 Global Inhalers And Nebulizers Price Forecast By Application (2023-2028) 48
6 North America 49
6.1 North America Inhalers And Nebulizers Market Size By Type 49
6.1.1 North America Inhalers And Nebulizers Sales By Type (2017-2028) 49
6.1.2 North America Inhalers And Nebulizers Revenue By Type (2017-2028) 50
6.2 North America Inhalers And Nebulizers Market Size By Application 51
6.3 North America Inhalers And Nebulizers Sales By Country 52
6.3.1 North America Inhalers And Nebulizers Sales By Country (2017-2028) 52
6.3.2 North America Inhalers And Nebulizers Revenue By Country (2017-2028) 54
6.3.3 United States 55
6.3.4 Canada 56
6.3.5 Mexico 56
7 Europe 57
7.1 Europe Inhalers And Nebulizers Market Size By Type 57
7.1.1 Europe Inhalers And Nebulizers Sales By Type (2017-2028) 57
7.1.2 Europe Inhalers And Nebulizers Revenue By Type (2017-2028) 58
7.2 Europe Inhalers And Nebulizers Market Size By Application 59
7.3 Europe Inhalers And Nebulizers Market Size By Country 60
7.3.1 Europe Inhalers And Nebulizers Sales By Country (2017-2028) 60
7.3.2 Europe Inhalers And Nebulizers Revenue By Country (2017-2028) 62
7.3.3 Germany 63
7.3.4 France 64
7.3.5 U.K. 64
7.3.6 Italy 65
7.3.7 Russia 65
8 Asia Pacific 66
8.1 Asia Pacific Inhalers And Nebulizers Market Size By Type 66
8.1.1 Asia Pacific Inhalers And Nebulizers Sales By Type (2017-2028) 66
8.1.2 Asia Pacific Inhalers And Nebulizers Revenue By Type (2017-2028) 67
8.2 Asia Pacific Inhalers And Nebulizers Market Size By Application 68
8.3 Asia Pacific Inhalers And Nebulizers Market Size By Region 69
8.3.1 Asia Pacific Inhalers And Nebulizers Sales By Region (2017-2028) 69
8.3.2 Asia Pacific Inhalers And Nebulizers Revenue By Region (2017-2028) 71
8.3.3 China 72
8.3.4 Japan 73
8.3.5 South Korea 73
8.3.6 India 74
8.3.7 Australia 74
8.3.8 Southeast Asia 75
9 South America 76
9.1 South America Inhalers And Nebulizers Market Size By Type 76
9.1.1 South America Inhalers And Nebulizers Sales By Type (2017-2028) 76
9.1.2 South America Inhalers And Nebulizers Revenue By Type (2017-2028) 77
9.2 South America Inhalers And Nebulizers Market Size By Application 78
9.3 South America Inhalers And Nebulizers Market Size By Country 79
9.3.1 South America Inhalers And Nebulizers Sales By Country (2017-2028) 79
9.3.2 South America Inhalers And Nebulizers Revenue By Country (2017-2028) 81
9.3.3 Brazil 82
10 Middle East And Africa 83
10.1 Middle East And Africa Inhalers And Nebulizers Market Size By Type 83
10.1.1 Middle East And Africa Inhalers And Nebulizers Sales By Type (2017-2028) 83
10.1.2 Middle East And Africa Inhalers And Nebulizers Revenue By Type (2017-2028) 84
10.2 Middle East And Africa Inhalers And Nebulizers Market Size By Application 85
10.3 Middle East And Africa Inhalers And Nebulizers Market Size By Country 87
10.3.1 Middle East And Africa Inhalers And Nebulizers Sales By Country (2017-2028) 87
10.3.2 Middle East And Africa Inhalers And Nebulizers Revenue By Country (2017-2028) 87
10.3.3 Middle East 89
10.3.4 Africa 89
11 Corporate Profile 90
11.1 Gsk 90
11.1.1 Gsk Corporation Information 90
11.1.2 Gsk Overview 90
11.1.3 Gsk Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 91
11.1.4 Gsk Inhalers And Nebulizers Product Introduction 91
11.1.5 Gsk Recent Developments 93
11.2 Astrazeneca 94
11.2.1 Astrazeneca Corporation Information 94
11.2.2 Astrazeneca Overview 94
11.2.3 Astrazeneca Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 95
11.2.4 Astrazeneca Inhalers And Nebulizers Product Introduction 95
11.2.5 Astrazeneca Recent Developments 96
11.3 Chiesi 97
11.3.1 Chiesi Corporation Information 97
11.3.2 Chiesi Overview 97
11.3.3 Chiesi Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 98
11.3.4 Chiesi Inhalers And Nebulizers Product Introduction 98
11.4 Boehringer Ingelheim 100
11.4.1 Boehringer Ingelheim Corporation Information 100
11.4.2 Boehringer Ingelheim Overview 101
11.4.3 Boehringer Ingelheim Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 101
11.4.4 Boehringer Ingelheim Inhalers And Nebulizers Product Introduction 102
11.4.5 Boehringer Ingelheim Recent Developments 102
11.5 Novartis 103
11.5.1 Novartis Corporation Information 103
11.5.2 Novartis Overview 103
11.5.3 Novartis Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 104
11.5.4 Novartis Inhalers And Nebulizers Product Introduction 105
11.5.5 Novartis Recent Developments 106
11.6 Teva 107
11.6.1 Teva Corporation Information 107
11.6.2 Teva Overview 107
11.6.3 Teva Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 108
11.6.4 Teva Inhalers And Nebulizers Product Introduction 108
11.7 Organon 109
11.7.1 Organon Corporation Information 109
11.7.2 Organon Overview 110
11.7.3 Organon Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 111
11.7.4 Organon Inhalers And Nebulizers Product Introduction 111
11.7.5 Organon Recent Developments 112
11.8 Pari Gmbh 113
11.8.1 Pari Gmbh Corporation Information 113
11.8.2 Pari Gmbh Overview 114
11.8.3 Pari Gmbh Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 114
11.8.4 Pari Gmbh Inhalers And Nebulizers Product Introduction 115
11.9 Omron 116
11.9.1 Omron Corporation Information 116
11.9.2 Omron Overview 116
11.9.3 Omron Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 117
11.9.4 Omron Inhalers And Nebulizers Product Introduction 117
11.10 Philips 118
11.10.1 Philips Corporation Information 118
11.10.2 Philips Overview 119
11.10.3 Philips Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 119
11.10.4 Philips Inhalers And Nebulizers Product Introduction 120
11.11 Drive Devilbiss Healthcare 121
11.11.1 Drive Devilbiss Healthcare Corporation Information 121
11.11.2 Drive Devilbiss Healthcare Overview 121
11.11.3 Drive Devilbiss Healthcare Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 122
11.11.4 Drive Devilbiss Healthcare Inhalers And Nebulizers Product Introduction 122
11.12 Yuwell 124
11.12.1 Yuwell Corporation Information 124
11.12.2 Yuwell Overview 124
11.12.3 Yuwell Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 125
11.12.4 Yuwell Inhalers And Nebulizers Product Introduction 125
11.13 Leyi 126
11.13.1 Leyi Corporation Information 126
11.13.2 Leyi Overview 127
11.13.3 Leyi Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 128
11.13.4 Leyi Inhalers And Nebulizers Product Introduction 128
11.14 Folee 129
11.14.1 Folee Corporation Information 129
11.14.2 Folee Overview 130
11.14.3 Folee Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 130
11.14.4 Folee Inhalers And Nebulizers Product Introduction 130
11.15 Beurer 131
11.15.1 Beurer Corporation Information 131
11.15.2 Beurer Overview 132
11.15.3 Beurer Inhalers And Nebulizers Sales, Price, Revenue And Gross Margin (2017-2022) 132
11.15.4 Beurer Inhalers And Nebulizers Product Introduction 133
12 Industry Chain And Sales Channels Analysis 134
12.1 Inhalers And Nebulizers Industry Chain Analysis 134
12.2 Inhalers And Nebulizers Key Raw Materials 135
12.2.1 Key Raw Materials 135
12.2.2 Raw Materials Key Suppliers 135
12.3 Inhalers And Nebulizers Production Mode & Process 136
12.4 Inhalers And Nebulizers Sales And Marketing 137
12.4.1 Inhalers And Nebulizers Sales Channel 137
12.4.2 Inhalers And Nebulizers Distributors 139
12.5 Inhalers And Nebulizers Customers 141
13 Inhalers And Nebulizers Market Dynamics 144
13.1.1 Inhalers And Nebulizers Industry Trends 144
13.1.2 Inhalers And Nebulizers Market Drivers 145
13.1.3 Inhalers And Nebulizers Market Challenges 146
13.1.4 Inhalers And Nebulizers Market Restraints 146
14 Key Findings In The Global Inhalers And Nebulizers Study 147
15 Appendix 149
15.1 Research Methodology 149
15.1.1 Methodology/Research Approach 149
15.1.2 Data Source 153
15.2 Author Details 156
15.3 Disclaimer 157

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/25 10:26

155.25 円

163.23 円

198.36 円

ページTOPに戻る